Skip to main content

Table 1 Patient’s characteristics

From: The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

  

all patients

Q I

Q II

Q III

Q IV

Q V

P

n

 

340

68

68

68

68

68

 

log (TG).HDL-C-1

 

0.045

0.026

0.035

0.042

0.050

0.071

~

age

years

67 (13)

67 (13)

66 (13)

67 (13)

68 (12)

65 (14)

NS

diabetes duration

years

15 (10)

15 (10)

14 (9)

15 (11)

16 (9)

17 (9)

NS

smoking

§

%

72-28

75-25

77-23

72-28

68-32

68-32

NS

ethanol

U.week-1

5 (11)

9 (14)

8 (13)

5 (11)

3 (6)

2 (3)

0.0001

education

%

71:29

56:44

69:31

73:27

75:25

82:18

0.0007

hypertension

%

85

78

82

85

88

91

0.0181

Hb A1c

%

7.87 (1.62)

7.50 (1.82)

7.50 (1.54)

7.94 (1.62)

8.06 (1.50)

8.34 (1.49)

0.0073

Hb A1c

mmol.mol-1

63 (13)

58 (14)

59 (12)

63 (13)

65 (12)

68 (12)

<0.0001

microangiopathy

%

51

40

45

55

58

60

0.0045

retinopathy

%

30

24

27

40

31

29

NS

peripheral polyneuropathy

%

25

19

16

25

41

28

0.0111

macroangiopathy

%

22

16

18

28

19

26

NS

Epworth score

 

6 (4)

5 (4)

6 (4)

5 (3)

7 (5)

7 (4)

0.0066

pathological (>9)

%

18

9

17

12

25

25

0.0066

OSAS

%

6

0

1

9

7

12

0.0011

  1. Results are expressed as means (1SD) or proportions (%) §: never vs. former/current; HbA1c:glycated haemoglobin; HDL-C: high density lipoprotein cholesterol; OSAS: obstructive sleep apnea/hyponea syndrome; Q: quintile; TG: triglycerides; NS: not significant.